Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
Pharma Tech
J&J’s Imaavy secures expanded US approval in rare blood disorder
The FDA approval marks another successful step in J&J’s aim of achieving $5bn in peak sales for the drug.
Read Full Article
Pharma Tech
BMS Texas investment advances pharma’s modular manufacturing agenda
BMS is investing $2.3bn in a new campus in Houston, Texas, which will have flexibility firmly embedded in its construction.
Read Full Article
Pharma Tech
Formulation as a key differentiator in crowded therapeutic areas
Formulation differentiates therapies in crowded markets by improving adherence, tolerability, convenience, and delivery efficiency.
Read Full Article
Pharma Tech
Asia’s clinical research revolution: Why the world’s innovation centre is shifting east
APAC is becoming a clinical research hub as China, Japan and South Korea accelerate trials.
Read Full Article
Pharma Tech
GSK snags Japanese approval for first hepatitis B functional cure, Hibsago
Analysts are heralding functional cures like Hibsago in chronic hepatitis B as the next frontier in treatment for patients.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Aug 26, 2026, 2:20 AM
More US employers to drop weight-loss drugs in 2027, as healthcare costs increase
Two-thirds of employers surveyed said they saw rising utilization of the drugs. GLP-1 weight-loss drugs, such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo.
ET Pharma
Aug 26, 2026, 2:15 AM
US plans to appoint two new FDA deputy commissioners for tech and drugs: Report
One role would focus on technology, including healthcare and AI, while the other would oversee drugs, according to two people familiar with the plans.
ET Pharma
Aug 26, 2026, 2:14 AM
Natco to infuse $14 million in US biotech eGenesis
Under the $14-million funding, Natco’s Canadian-arm will contribute $9.5 million, with the remaining amount will be infused by the company’s South African subsidiary.
ET Pharma
Aug 26, 2026, 12:26 AM
Aurigene secures long-term manufacturing contract from global pharma firm
The contract initially covers over 20 products including sterile injectables, biologics and topicals, to be manufactured across facilities in India through a phased technology transfer program over the next two to three years. Revenue is projected to commence from 2028.
Pharma Tech
Aug 25, 2026, 3:38 PM
J&J’s Imaavy secures expanded US approval in rare blood disorder
The FDA approval marks another successful step in J&J’s aim of achieving $5bn in peak sales for the drug.
Pharma Tech
Aug 25, 2026, 3:37 PM
BMS Texas investment advances pharma’s modular manufacturing agenda
BMS is investing $2.3bn in a new campus in Houston, Texas, which will have flexibility firmly embedded in its construction.
News
Latest industry coverage
Google News
Aug 26, 2026, 3:43 AM
AI-Powered Moderna Stuns Markets with Interim Report: MistRx Leads China's Booming AI4S Innovation Track - 36 Kr
AI-Powered Moderna Stuns Markets with Interim Report: MistRx Leads China's Booming AI4S Innovation Track 36 Kr
Google News
Aug 26, 2026, 3:19 AM
SK Biopharmaceuticals signs $795 million licensing deal with Biohaven for epilepsy drug - Korea JoongAng Daily
SK Biopharmaceuticals signs $795 million licensing deal with Biohaven for epilepsy drug Korea JoongAng Daily
Google News
Aug 26, 2026, 2:17 AM
McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets - pharma.economictimes.indiatimes.com
McKesson strikes $2.25 billion Precision Medicine deal in clinical research bets pharma.economictimes.indiatimes.com
Google News
Aug 26, 2026, 2:15 AM
US plans to appoint two new FDA deputy commissioners for tech and drugs: Report - pharma.economictimes.indiatimes.com
US plans to appoint two new FDA deputy commissioners for tech and drugs: Report pharma.economictimes.indiatimes.com
Google News
Aug 26, 2026, 2:14 AM
Natco to infuse $14 million in US biotech eGenesis - pharma.economictimes.indiatimes.com
Natco to infuse $14 million in US biotech eGenesis pharma.economictimes.indiatimes.com
Google News
Aug 26, 2026, 1:46 AM
Honasa Consumer scraps 58% Fluence Pharma stake acquisition - India IPO
Honasa Consumer scraps 58% Fluence Pharma stake acquisition India IPO
Google News
Aug 26, 2026, 1:24 AM
Nearly 15 Trillion Won in the Second Half Already... China's 'Bio Ambition' Accelerates - 아시아경제
Nearly 15 Trillion Won in the Second Half Already... China's 'Bio Ambition' Accelerates 아시아경제
Google News
Aug 26, 2026, 1:00 AM
China rushes to develop Moderna-style cancer vaccines amid market frenzy - South China Morning Post
China rushes to develop Moderna-style cancer vaccines amid market frenzy South China Morning Post
Google News
Aug 26, 2026, 12:47 AM
Taiwan maps four AI-led strategies to expand its biotech sector - digitimes
Taiwan maps four AI-led strategies to expand its biotech sector digitimes
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer